Non-alcoholic fatty liver disease ultrasound: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Non alcoholic fatty liver disease}} | {{Non alcoholic fatty liver disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{MKK}} | ||
{{ | |||
==Overview== | ==Overview== | ||
Ultrasound may be helpful in the diagnosis of | [[Ultrasound]] may be helpful in the diagnosis of non-alcoholic fatty liver disease. Increased echogenicity and coarsened echotexture of the liver is the most prominent and diagnostic finding on an ultrasound in patients diagnosed non-alcoholic fatty liver disease. | ||
==Ultrasound== | ==Ultrasound== | ||
*Ultrasound | *Ultrasound is considered as the first line of imaging choice for NAFLD patients | ||
*Ultrasound have senstivity of 60-100 and | *Ultrasound have senstivity of 60-100 and 80-100 % of positive predictive value. | ||
*Findings on an ultrasound suggestive of | *Findings on an ultrasound suggestive of non-alcoholic fatty liver disease include: | ||
** | **Moderate to high amount of fatty infiltration of liver which is reflected as increased echogenicity and coarsened echotexture of the liver. | ||
** | ** If steato-hepatitis has progressed to cirrhosis, a nodular liver surface may be present in addition to other fibrotic changes.<ref name="pmid28994271">{{cite journal |vauthors=Lee DH |title=Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification |journal=Clin Mol Hepatol |volume= |issue= |pages= |year=2017 |pmid=28994271 |doi=10.3350/cmh.2017.0042 |url=}}</ref> | ||
*Ultrasound elastography is another kind of ultrasound that can give [[qualitative]] progression of the liver fibrosis. | |||
*The only limitation of using an ultrasound is that it cannot differentiate between [[hepatic fibrosis]] and [[steatosis]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 03:24, 30 July 2018
|
Non-Alcoholic Fatty Liver Disease Microchapters |
|
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case studies |
|
Non-alcoholic fatty liver disease ultrasound On the Web |
|
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease ultrasound |
|
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
|
Risk calculators and risk factors for Non-alcoholic fatty liver disease ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Ultrasound may be helpful in the diagnosis of non-alcoholic fatty liver disease. Increased echogenicity and coarsened echotexture of the liver is the most prominent and diagnostic finding on an ultrasound in patients diagnosed non-alcoholic fatty liver disease.
Ultrasound
- Ultrasound is considered as the first line of imaging choice for NAFLD patients
- Ultrasound have senstivity of 60-100 and 80-100 % of positive predictive value.
- Findings on an ultrasound suggestive of non-alcoholic fatty liver disease include:
- Moderate to high amount of fatty infiltration of liver which is reflected as increased echogenicity and coarsened echotexture of the liver.
- If steato-hepatitis has progressed to cirrhosis, a nodular liver surface may be present in addition to other fibrotic changes.[1]
- Ultrasound elastography is another kind of ultrasound that can give qualitative progression of the liver fibrosis.
- The only limitation of using an ultrasound is that it cannot differentiate between hepatic fibrosis and steatosis.
References
- ↑ Lee DH (2017). "Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification". Clin Mol Hepatol. doi:10.3350/cmh.2017.0042. PMID 28994271.